Research reading
Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale demand and the Lesotho (LSO) to South Africa (ZAF) lane
South Africa (ZAF) reported $2.5M of blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale imports in 2024. Lesotho (LSO) accounted for 0% of the observed market and reported $0.0 in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +46.2% buyer growth and -23.2% exporter growth. The page separates reported values from projections and indicators.
